SCHEMBL418090

SCHEMBL418090

CC(C)(C)c1ccco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28546834 0.85 MAPT (0.43)
SCHEMBL181942 0.83 MAPT (0.48)
SCHEMBL28297060 0.83 MAPT (0.48)
SCHEMBL4983413 0.83 MAPT (0.48)
SCHEMBL28217512 0.81
SCHEMBL15796374 0.81 MAPT (0.47)
SCHEMBL7629307 0.79
SCHEMBL2325591 0.79
SCHEMBL13994295 0.79
SCHEMBL20734518 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1670 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12265087-B2 Olfactory receptor as microglia marker and use thereof DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-04-01 US claimed
US-20220357342-A1 OLFACTORY RECEPTOR AS MICROGLIA MARKER AND USE THEREOF DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-11-10 US claimed
US-10988488-B2 Process for the functionalization of sp2-H carbons using frustrated lewis pair catalysts UNIVERSITé LAVAL (CA) 2021-04-27 US claimed
US-20180094001-A1 PROCESS FOR THE FUNCTIONALIZATION OF SP2-H CARBONS USING FRUSTRATED LEWIS PAIR CATALYSTS UNIVERSITE LAVAL (CA) 2018-04-05 US claimed
US-20010053833-A1 Metallocene compound, olefin polymerization catalyst containing the compound, and method for producing an olefin polymer by use of the catalyst CHISSO CORPORATION (JP) 2001-12-20 US claimed
US-12396977-B2 Composition for treating degenerative brain diseases, containing 2-pentylfuran as active ingredient DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-08-26 US disclosed
US-12265087-B2 Olfactory receptor as microglia marker and use thereof DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2025-04-01 US disclosed
US-20250101034-A1 COMPOSITIONS USEFUL FOR MODULATING SPLICING SKYHAWK THERAPEUTICS, INC. 2025-03-27 US disclosed
WO-2025062334-A1 4-((5-(3-(4-(PYRIDIN-2-YL)CYCLOPENTYL)-1 H-PYRAZOL-3-YL)AMINO)-BENZENESULFONAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS CDK INHIBITORS FOR THE TREATMENT OF CANCER BEIGENE SWITZERLAND GMBH (CH) 2025-03-27 WO disclosed
US-12036209-B2 Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides ARVINAS OPERATIONS, INC. (US) 2024-07-16 US disclosed
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2024-07-11 US disclosed
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2024-07-11 US disclosed
WO-1999028300-A1 SUBSTITUTED IMIDAZOLE DERIVATIVES HAVING AGONIST-LIKE ACTIVITY AT ALPHA 2B OR 2B/2C ADRENERGIC RECEPTORS ALLERGAN SALES, INC. (US) 1999-06-10 WO disclosed
WO-1998052558-A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS BAYER CORPORATION (US) 1998-11-26 WO disclosed
WO-1998052559-A1 RAF KINASE INHIBITORS BAYER CORPORATION (US) 1998-11-26 WO disclosed
EP-0253502-A2 Tertiary amine compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-01-20 EP disclosed
EP-0041775-B1 PROCESS FOR THE PREPARATION OF ALKYL FURANS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-07-18 EP disclosed
EP-0107366-A1 Pyrrolidinone analogs and precursors ELI LILLY AND COMPANY (US) 1984-05-02 EP disclosed
US-4323509-A Process for the preparation of alkyl furans IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-04-06 US disclosed
EP-0041775-A1 Process for the preparation of alkyl furans IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-12-16 EP disclosed